| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,118 | 11,534 | 12,363 | 13,447 | | Cost of Revenue | 6,502 | 6,267 | 7,110 | 8,823 | | | Gross Profit | 6,616 | 5,267 | 5,253 | 4,624 | | | Operating Expenses | | Research Development | 7,839 |
-
|
-
|
-
| | Selling General and Administrative | (2,626) | 5,696 | 7,253 | 8,363 | | Non Recurring |
-
|
-
|
-
| 13,747 | | Others | 1,272 | 1,461 | 1,682 | 2,035 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 131 | (1,890) | (3,682) | (19,521) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (723) | | Earnings Before Interest And Taxes | 17 | (1,890) | (3,682) | (20,244) | | Interest Expense | (91) | (42) | 133 | 48 | | Income Before Tax | 108 | (1,848) | (3,815) | (20,292) | | Income Tax Expense | 85 | 92 | 85 | 4 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 23 | (1,940) | (3,900) | (20,296) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23 | (1,940) | (3,900) | (20,296) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $23 | ($1,940) | ($3,900) | ($20,296) |
|
0.31% Nasdaq 0.00%
Income Statement
